Претраживање
Приказ резултата 1-1 од 1
Iodide analogs of arsenoplatins - potential drug candidates for triple negative breast cancers
(MDPI, 2021)
Patients with triple negative breast cancers (TNBCs)—highly aggressive tumors that do not express estrogen, progesterone, and human epidermal growth factor 2 receptors—have limited treatment options. Fewer than 30% of women ...